Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer

Publication

Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer

Journal Paper/Review - Jan 13, 2014

Lorente David, Chowdhury Simon, Attard Gerhardt, Zivi Andrea, Ferraldeschi Roberta, Pezaro Carmel, Omlin Aurelius, Rodriguez-Vida Alejo, Bianchini Diletta, de Bono Johann S

Citation

Lorente D, Chowdhury S, Attard G, Zivi A, Ferraldeschi R, Pezaro C, Omlin A, Rodriguez-Vida A, Bianchini D, de Bono J. Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer. Eur J Cancer 2014; 50:1042-3.

Type

Journal Paper/Review (English)

Journal

Eur J Cancer 2014; 50

Publication Date

Jan 13, 2014

Issn Electronic

1879-0852

Pages

1042-3